Literature DB >> 20089876

Effects of sildenafil and tadalafil on intraocular pressure in sheep: implications for aqueous humor dynamics.

Rosana Gerometta1, Lawrence J Alvarez, Oscar A Candia.   

Abstract

PURPOSE: To determine the effects of vasodilators on intraocular pressure (IOP) and the protein content of sheep aqueous humor (AH), because the vasodilators may increase fluid leakage from the fenestrated capillaries of the ciliary body to the extracellular tissue and directly to the anterior chamber (AC) via the iris, and some senior patients (older than 70) treated with sildenafil have exhibited elevated IOP.
METHODS: Experiments were performed on domestic sheep residing on a ranch in Argentina. These docile and compliant animals readily swallowed tablets of sildenafil (50 and 100 mg) and tadalafil (20 mg). IOP was monitored by Perkins applanation tonometry in 21 normal sheep receiving orally administered drugs. In addition, paracentesis was performed on six sheep to quantify changes in AH protein levels.
RESULTS: Ingestion of both sildenafil and tadalafil increased sheep IOP from normal levels of approximately 9 to 11 mm Hg within 1 hour. The IOP elevation was approximately 1.6-fold with both doses of sildenafil. IOP returned to control values within 4 hours. With the longer-lasting vasodilator tadalafil, IOP remained 1.6- to 1.9-fold higher than normal for at least 48 hours and returned to control levels within 4 days. The AH protein content was approximately 39% higher in sheep given 100 mg sildenafil.
CONCLUSIONS: These data are consistent with a vasodilator-evoked increase in plasma-like fluid in the AC, which likely accounts for the IOP elevation. The results are discussed with a model for AH dynamics that may be of importance to senior individuals treated for vascular diseases with these compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089876      PMCID: PMC2891473          DOI: 10.1167/iovs.09-4862

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Blood circulation and fluid dynamics in the eye.

Authors:  A Bill
Journal:  Physiol Rev       Date:  1975-07       Impact factor: 37.312

2.  Effects of vardenafil on intraocular pressure and orbital hemodynamics.

Authors:  Pelin Taner; M Murad Başar; Birsen Unal; Ertan Batislam
Journal:  J Ocul Pharmacol Ther       Date:  2007-06       Impact factor: 2.671

3.  Effect of Viagra on the foveolar choroidal circulation of AMD patients.

Authors:  Tatyana I Metelitsina; Juan E Grunwald; Joan C DuPont; Gui-shuang Ying
Journal:  Exp Eye Res       Date:  2005-08       Impact factor: 3.467

4.  NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.

Authors:  Mohammad Shahidullah; Nicholas A Delamere
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

5.  Effect of 8-Br cGMP on aqueous humor dynamics in monkeys.

Authors:  C Kee; P L Kaufman; B T Gabelt
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-05       Impact factor: 4.799

6.  Choroidal myogenic autoregulation and intraocular pressure.

Authors:  J W Kiel
Journal:  Exp Eye Res       Date:  1994-05       Impact factor: 3.467

7.  Effects of sildenafil citrate on human hemodynamics.

Authors:  G Jackson; N Benjamin; N Jackson; M J Allen
Journal:  Am J Cardiol       Date:  1999-03-04       Impact factor: 2.778

8.  The effects of sildenafil on ocular blood flow.

Authors:  Murat Koksal; Huseyin Ozdemir; Sebnem Kargi; Cetin Yesilli; Sühan Tomaç; Kamran Mahmutyazicioglu; Aydin Mungan
Journal:  Acta Ophthalmol Scand       Date:  2005-06

9.  Sildenafil increases ocular perfusion.

Authors:  G Paris; W E Sponsel; S S Sandoval; W R Elliott; Y Trigo; D K Sanford; J M Harison
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

Review 10.  Phosphodiesterase-5 inhibitors: future perspectives.

Authors:  Giannitsas Konstantinos; Perimenis Petros
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

View more
  13 in total

1.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

2.  Sildenafil accelerates anterior chamber refilling after paracentesis in sheep and rabbits.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

3.  Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers.

Authors:  Rosana Gerometta; Lawrence J Alvarez; Oscar A Candia
Journal:  Exp Eye Res       Date:  2011-05-30       Impact factor: 3.467

Review 4.  Precautions and Monitoring of Patients Taking Phosphodiesterase Type 5 Inhibitors Who are at Risk of Increased Intraocular Pressure.

Authors:  Joshua C Baker; Robert Fintelmann; Roohollah Sharifi; Mary Lee
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

5.  Sildenafil stimulates aqueous humor turnover in rabbits.

Authors:  Lawrence J Alvarez; Aldo C Zamudio; Oscar A Candia
Journal:  Exp Eye Res       Date:  2013-04-02       Impact factor: 3.467

Review 6.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

7.  Gene expression and functional annotation of the human ciliary body epithelia.

Authors:  Sarah F Janssen; Theo G M F Gorgels; Koen Bossers; Jacoline B Ten Brink; Anke H W Essing; Martijn Nagtegaal; Peter J van der Spek; Nomdo M Jansonius; Arthur A B Bergen
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

Review 9.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction.

Authors:  Marilita M Moschos; Eirini Nitoda
Journal:  Drug Des Devel Ther       Date:  2016-10-19       Impact factor: 4.162

10.  Sildenafil dilates ophthalmic artery in type 2 diabetic patients.

Authors:  Akeel Amh Zwain; Najah R Hadi; Ahmed M Al-Mudhaffer
Journal:  SAGE Open Med       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.